Figure 1From: The impact of secondary hyperparathyroidism on the efficacy of antiresorptive therapy Baseline parathormone levels in the responder and non-responder subsets (0: declining bone mineral density/non-responders/, 1: improving bone mineral density/responders/). Back to article page